Objective: The understanding of childhood absence epilepsy (CAE) has been revolutionized over the past decade, but the biological mechanisms responsible for variable treatment outcomes are unknown. Our purpose in this prospective observational study was to determine how pretreatment ictal network pathways, defined using a combined electroencephalography (EEG)-functional magnetic resonance imaging (EEG-fMRI) and magnetoencephalography (MEG) effective connectivity analysis, were related to treatment response. Methods: Sixteen children with newly diagnosed and drug-naive CAE had 31 typical absence seizures during EEG-fMRI and 74 during MEG. The spatial extent of the pretreatment ictal network was defined using fMRI hemodynamic response with an event-related independent component analysis (eICA). This spatially defined pretreatment ictal network supplied prior information for MEGeffective connectivity analysis calculated using phase slope index (PSI). Treatment outcome was assessed 2 years following diagnosis and dichotomized to ethosuximide (ETX)-treatment responders (N = 11) or nonresponders (N = 5). Effective connectivity of the pretreatment ictal network was compared to the treatment response. Results: Patterns of pretreatment connectivity demonstrated strongest connections in the thalamus and posterior brain regions (parietal, posterior cingulate, angular gyrus, precuneus, and occipital) at delta frequencies and the frontal cortices at gamma frequencies (P < .05). ETX treatment nonresponders had pretreatment connectivity, which was decreased in the precuneus region and increased in the frontal cortex compared to ETX responders (P < .05). Significance: Pretreatment ictal connectivity differences in children with CAE were associated with response to antiepileptic treatment. This is a possible mechanism for the variable treatment response seen in patients sharing the same epilepsy syndrome.
| INTRODUCTION
Childhood absence epilepsy (CAE) is considered by many to be a singular epilepsy syndrome but the associated clinical features are variable. Phenotypic groups of patients with CAE have been proposed based on differences in their pretreatment seizure semiology, electroencephalography (EEG), presence of attention deficits, and treatment response. 1, 2 Clinical outcome is clearly variable, with 19.5% of patients failing to respond to the first-line treatment, ethosuximide (ETX). [1] [2] [3] This individual variability also extends to the brain networks responsible for absence seizures. The epileptic network pathways previously identified for CAE are broad but include abnormal functioning in focal regions of the thalamus, frontal cortex, temporal cortex, precuneus, and cingulate gyri, with variation reported between patients. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Our group has described previously complex interactions between distinct, cooccurring, and frequency dependent parietal and frontal corticothalamic networks that are present at seizure onset and vary among individuals. 15 There have been no prior attempts to relate any of the variable neuroimaging patterns to the phenotypic variability seen in these patients. Likely, this has been difficult because previous studies have had heterogeneous patient populations in terms of age, duration of epilepsy, medications, and lack information regarding long term clinical outcome. 5, 6, [16] [17] [18] Another challenge has been that previous functional neuroimaging studies of CAE have employed either functional magnetic resonance imaging (fMRI) or magnetoencephalography (MEG) which, when used individually, are limited in their temporal or spatial resolution, respectively. 7, 8, 11, [13] [14] [15] 17, [19] [20] [21] [22] EEG-fMRI can provide excellent spatial information, which is necessary to define the structure of the seizure network, but it lacks the temporal resolution to fully characterize the rapid interactions that occur during a seizure. The high temporal resolution of MEG provides critical information regarding dynamic changes of the network. A multimodal imaging approach with combined EEG-fMRI and MEG has the potential to identify epileptic network pathways over multiple frequencies and with optimal spatial and temporal resolution, in a way that has not been possible previously. Children with newly diagnosed and untreated CAE present a unique opportunity to directly study ictal events using this multimodal approach, whereas most functional neuroimaging studies of human epilepsy are done during the interictal state, and the results are used to infer the epileptic networks responsible for generating seizures. We hypothesize that CAE patients who respond well to the best first-line treatment, ETX, have different pretreatment ictal connectivity patterns than those who are ETX nonresponders. Specifically, we propose that our fMRIinformed MEG effective connectivity analysis can identify the pretreatment epileptic network pathways of absence seizures and provide a mechanistic explanation for some of the phenotypic variability seen in this most common childhood epilepsy syndrome.
| METHODS

| Participants
Children (6-12 years) with newly diagnosed CAEs were recruited from the neurology division at Cincinnati Children's Hospital Medical Center (CCHMC). The research protocol received approval by the institutional review board prior to study recruitment. Written informed consent was obtained from the parent of each subject, and informed assent was obtained from each child. This patient population has been described previously. 15 Briefly, inclusion criteria included a diagnosis of CAEs, normal development (based on parental report), normal neurological examination (which grossly assessed cognition), normal brain MRI, and bilaterally synchronous 3-4 Hz spike and wave discharges on a normal background with at least one electroclinical seizure lasting 3 s or more. Children were not eligible if there was a history of seizures other than absence seizures (generalized tonic-clonic or myoclonic) or if they were currently taking an antiepileptic medication. Following the research recordings, all participants started treatment with ETX per the standardized pathway defined at CCHMC for patients with CAE, and dosing was per our clinical protocol within the division of neurology. Briefly, this protocol has a starting dose of 10 mg per kilogram of body weight divided twice daily, which is then increased every 1-2 weeks until freedom from
Key Points
• fMRI-informed MEG-effective connectivity analysis outlines a novel way to explore epileptic network pathways with high spatial and temporal resolution
• Regions critical for absence seizures (frontal cortex, precuneus, thalamus) have distinct MEG connectivity patterns that are frequency dependent
• Pretreatment MEG connectivity differs between ETX-treatment responders and nonresponders
• ETX-treatment nonresponders have decreased pretreatment parietal connectivity at low frequencies
• ETX treatment nonresponders have increased frontal connectivity at high frequencies seizures is attained. The maximum daily dose for ethosuximide (or ETX) is typically 60 mg per kilogram of body weight or 2000 mg per day. Clinical outcome was assessed at a minimum of 2 years after diagnosis by a review of the participant's outpatient medical chart. Follow-up data included the following: the total number and specific antiepileptic drug (AED) treatments, seizure outcome (seizure-free or continued seizures), remission (yes or no) defined as successful wean of AED treatment without subsequent relapse, and duration of follow-up. An ETX treatment responder was defined as a participant who was seizure-free, as assessed by parental report and follow-up routine EEG with no absence seizures (spike-wave bursts lasting ≥3 s). Participants who met these criteria but later had to discontinue ETX due to adverse effects were still considered responders. ETX treatment nonresponders were participants who never became seizure-free on adequate doses of ETX, either by parental report or routine EEG (spike-wave bursts lasting ≥3 s). These criteria are adapted from a previous double-blind, randomized, controlled drug trial in CAE. 2 Participants who became seizure-free on a subsequent AED were still considered as ETX nonresponders if they met these criteria.
| EEG-fMRI recordings
All participants had simultaneous EEG and fMRI recordings. MRI images were collected on a 3T Phillips Achieva MRI scanner (Philips, Andover, MA, USA) using a 32-channel head coil. An echo planar imaging sequence was used with blood oxygenation level-dependent (BOLD) weighting and full brain coverage (repetition time/echo time [TR/TE] = 2000/38 msec, field of view [FOV] 24 9 24 cm, matrix 64 9 64, slice thickness = 4 mm, resulting in a voxel size of 3.75 9 3.75 9 4 mm, 37 axial slices). In addition, a three-dimensional (3D) T1-weighted 1 mm isotropic anatomical image with fiducial markers was acquired for co-registration and alignment with both the fMRI and MEG. EEG was recorded with a sampling rate of 10 kHz during imaging using a 68-channel MRIcompatible EEG acquisition system (Maglink by Neuroscan, division of Compumedics Ltd, El Paso, TX, USA). Following recording, the algorithm included with the acquisition software (Scan 4.3) was used to remove scanner and cardioballistic artifact. EEG data were low pass filtered at 60 Hz and echo planar imaging (EPI)-gradient artifacts were averaged over the first 9 TR periods and then subtracted from each epoch of the raw data following methods that have been described previously. 23 Using the Scan software, this subtraction was improved by optimizing the temporal alignment based on the peak of the cross correlation between the average gradient waveform and the raw EEG data. Cardioballistic artifact was removed similarly using electrocardiography events as time marks. The EEG during fMRI was placed into a standard bipolar montage using 16 channels to retrospectively identify ictal events, which were later used for creating epochs and analysis of fMRI data. EEG-fMRI was recorded in 10-minute blocks (300 volumes) while participants were watching a movie.
| MEG recordings
Simultaneous EEG and MEG recordings were conducted using a 275 channel CTF MEG system with a sampling rate of 600 Hz (CTF Systems Inc., VSM MedTech Ltd., Coquitlam, BC, Canada). Recordings were completed on the same day as the EEG-fMRI. First, 21 MEG-compatible EEG electrodes were placed in the conventional 10-20 arrangement along with 1 channel of ECG. Fiducial markers were applied to 3 locations: at the nasion and each preauricular. A head localization procedure was performed before and after each acquisition to locate the patient's head relative to the coordinate system fixed to the MEG system. The coordinates of the 3 fiducial points, at the nasion and left and right preauricular, are determined electronically relative to the system Dewar coordinate frame. A new coordinate frame relative to the patients' head is derived from these positions. The change in head location before and after acquisition was required to be less than 5 mm for each recording in the study to be accepted. The protocol for MEG recording was similar to that used for conventional EEG. Data were sampled at 4 kHz and a third-order gradiometer was used for environmental noise cancellation. Continuous MEG recordings were completed in 5-minute time blocks and repeated 8 times for 40 minutes of total recording. If fewer than 2 seizures were recorded, then an additional 5 minutes of recording was completed while the patient was asked to hyperventilate to provoke a seizure. The recordings were monitored in real time to determine whether hyperventilation was necessary.
| EEG-fMRI analysis
The participant EEG recordings were reviewed by an experienced epileptologist (J.R.T.) and all generalized spike wave (GSW) bursts were identified. Those participants with 3 Hz GSW bursts lasting ≥3 s were included in the subsequent analysis. The fMRI images were preprocessed using Statistical Parametric Mapping version 8 (SPM8) (http:// www.fil.ion.ucl.ac.uk/spm), and the following steps were completed: rigid-body spatial realignment to correct for participant motion; slice timing to align slices within each volume to the first slice; spatial normalization into Montreal Neurological Institute (MNI) space; spatial smoothing with a Gaussian kernel (full width half maximum
A previously published event-related independent component analysis (eICA) method was used to identify the brain areas associated with absence seizures identified on EEG.
11 Briefly, this method is a 2-step process consisting of first, a linear deconvolution that provides the BOLD response at each voxel for the time of interest, and second, an independent component analysis (ICA), which determines the spatial extent of the event-related BOLD changes. After preprocessing, SPM8 was used to fit the fMRI time series to a general linear model (GLM) based on the timing of the absence seizure identified on the EEG and then generate a finite impulse response (FIR) basis set. Previous studies have identified BOLD signal changes earlier than the EEG onset of absence seizures, so the FIR basis set includes from À30 s to +30 s, relative to the EEG seizure onset, with a window of 2 s to correspond with the TR. The 6 motion parameters generated during preprocessing were used as regressors. The resulting FIR beta files generated in SPM8 were entered into a probabilistic ICA analysis using FSL's MELODIC (FMRIB's Software Library, www.fmrib.ox.ac.uk/fsl) to determine the underlying spatial sources. The ICA decomposition was performed on temporally concatenated data separately for each participant. In this way, each participant's event-related data were concatenated rather than the entire raw fMRI time series. An ICA decomposition of this concatenated event-related data gives the group-wise spatial maps. These spatial maps show positive and negative changes in z statistic maps (P < .05, family-wise error correction) with respect to the time course for each of the 5 components ( Figure 1A -E). It is assumed that those components with a consistent eventrelated time course, across the group, are the ones that represent the absence seizure network.
| fMRI-informed MEG connectivity analysis
The methods used for our combined fMRI and MEG connectivity analysis have been published previously by our group. 24 Briefly, the steps involved (1) parcellation of the fMRI activation map, (2) extraction of nodal time course from MEG data, and (3) effective connectivity analysis, so that the EEG-fMRI spatial information was used to guide the MEG connectivity analysis. The initial step was to parcellate the fMRI group activation maps for each of the 5 identified components. The activation maps were binarized so only suprathreshold voxels remained, and this activation was multiplied by a random 200-unit parcellation scheme. 25 This size parcellation is thought to provide a good balance between anatomical interpretations and functional homogeneity. Centroids of parcels with <10 active voxels provide the spatial coordinates of the seizure network nodes. Initially, the data were filtered from 0.1 to 70 Hz with line noise suppression with a 60-Hz notch filter. The participant EEG, recorded simultaneously with MEG, were reviewed by an experienced epileptologist (J.R.T.) in a standard bipolar montage and all GSW bursts were identified. Those 3 Hz GSW bursts lasting ≥3 s were included in the subsequent analysis. The first 3 s of each seizure was used for analysis, since seizures varied in total duration, but all were at least 3 s. Multiple seizures in a subject were temporally concatenated. MEG preprocessing was completed using FieldTrip. 26 The 3 s seizure segments were baseline corrected and power line noise (60 Hz), and first and second superharmonics were attenuated with a very sharp discrete Fourier transform filter. Forward modeling was completed in SPM8 so that each participant's T1-weighted MRI was segmented and the MNI 152 template was warped to subject space. Fiducial locations were manually identified on each participant's anatomical MRI so the MEG could be co-registered. Realistic single shell head models were constructed from the segmented images. The neuromagnetic activity at each node specified from the fMRI activation map was computed using a linearly constrained minimum variance (LCMV) beamformer from FieldTrip within SPM8. The effective connectivity analysis was estimated between each pair of prespecified nodes using the phase slope index (PSI). [27] [28] [29] This metric is based on the complex coherence function for a pair of signals with directionality inferred from phase differences over a specified frequency range. A PSI value for each node pair was computed in 3 frequency bands (3-4 Hz, 13-30 Hz, 30-55 Hz), which was based on a time-frequency transformation of the data to determine the points of maximum power (Figure 2 ). The 3 s segments of seizures were epoched for analysis into 1 s bins, so the minimum number of trials used for connectivity analysis was 6. Significant connectivity was determined by thresholding the data to PSI ≥ 1.65 (corrected for multiple comparisons) which corresponds to the critical value of a one-tailed z test at alpha = 0.05.
| Statistical analysis
Comparison of group demographics between ETX treatment responders and nonresponders was completed using a nonparametric (Mann-Whitney) test for age at diagnosis, number of AEDs, number of seizures during MEG recording, and seizure duration (during MEG). A chi-square test for proportions was used to compare sex. Degree, or the number of outgoing suprathreshold connections, for each node was calculated to compare connectivity between participants who were medication (ETX) responders and nonresponders. This was calculated for each node by binarizing the PSI values to 0 or 1 (presence or absence of a connection). Degree for each node was then averaged, within each frequency band, across participants within each outcome group. Node degree for the 2 clinical outcome groups (ETX treatment responders and nonresponders) were compared using a Fisher's exact test with a significance level of P ≤ .05, corrected for multiple comparisons.
The STROBE criteria were followed in the preparation of this manuscript (Data S1).
| RESULTS
| Participants
Eighteen pretreatment participants were recruited for the study, and 2 could not complete both recordings due to anxiety related to the testing. The remaining 16 participants (9 female, 7 male) had a mean age at diagnosis and testing of 8.8 years (range 6.0-11.8). This age at diagnosis represents the participants' age at the time the diagnosis of CAE was made by a neurologist. All participants were initially treated with ETX, and 11 became seizure-free with this treatment while the other 5 had continued seizures. Three of the ETX responders had to switch AED treatment due to intolerable side effects but remained seizure-free on the second-line treatment, valproic acid (VPA). Nine ETX responders were off medication and in remission at the time of follow-up, while 2 had failed a medication wean of ETX and the treatment was restarted. One of the 5 ETX nonresponders eventually became seizure-free following 2 other treatment trials, but the remaining 4 ETX nonresponders continued to have seizures despite additional AED treatments. None of the ETX nonresponders were in remission. There were no statistically significant differences in age at diagnosis (P = .91), sex (P = .2), number of seizures recorded during MEG (P = .13), and mean seizure duration (P = .11) ( Table 1) . However, there were a significantly greater number of AEDs since diagnosis in the ETX nonresponder group (P = .003).
| EEG-fMRI
Eight pretreatment participants (6 treatment responders, 2 treatment nonresponders) had a total of 31 pretreatment absence seizures (range 1-10) recorded with EEG-fMRI. The remaining 8 participants did not have seizures during their pretreatment EEG-fMRI. Five components resulted from the ICA analysis, which identified patterns of activity similar to that which have been reported previously (Figure 1A-E) . 4, 7, 8, [11] [12] [13] Areas with time courses that correlated positively with the seizure time course included the inferior/middle/posterior frontal, temporal, and thalamus. Brain regions with negative correlation in relation to the seizures included the posterior cingulate, parietal, angular, precuneus, and occipital. These fMRI activation maps were subsequently transformed into 41 total nodes, with spatially larger areas of activity comprised more nodes. previously published results with MEG in this patient population (Figure 2) . 15 All subsequent connectivity analyses were completed using these 3 bandwidths. The strongest connections for both ETX treatment responders and nonresponders at the 3-4 Hz delta frequency were mostly in the thalamus and posterior brain regions including the parietal, posterior cingulate, angular gyrus, precuneus, and occipital ( Figure 3 ). Treatment nonresponders have a majority of strongest connections in the right posterior brain regions, whereas responders had a more equal distribution between left and right posterior connections. The significance of these laterality differences is unclear in this small sample but should be explored further in future studies. There were less frequent connections within the frontal cortex at this lower frequency. At the higher gamma frequency bandwidth, there were stronger connections within the frontal cortices and a reduced number of significant connections in the posterior brain regions. Degree was calculated for each node and averaged across subjects in each of the 2 groups (ETX treatment responders and nonresponders) (Figure 4) . At 3-4 Hz there were significantly increased connections for 4 nodes in the right parietal in the ETX treatment responder group (P < .01). These nodes were specifically located within the right precuneus. ETX treatment nonresponders had an increased number of connections at one node in the left occipital lobe and one node in the left frontal lobe within the beta (13-30 Hz) frequency (P < .05). These were specifically located in the left calcarine cortex and the left inferior frontal gyrus. Likewise, at gamma frequencies , the ETX treatment responders also had increased connections within 2 nodes of the left inferior frontal gyrus (P < .01). 
Pvalue
Age at diagnosis (years) Mean duration of seizures recorded during MEG and used for subsequent connectivity analysis.
F I G U R E 3
Results of fMRI-informed MEG connectivity analysis. The circular connectivity plots show the 41 nodes representing the BOLD fMRI results, which are organized by hemisphere and major brain area, with anterior regions at the top and posterior regions at the bottom with thalamic nodes at the bottom of the circle. Lines connecting the nodes show connectivity between regions with line thickness relative to the PSI value (strength of connection) and the color indicating the direction of information flow (color of the connection corresponds to the driver node). Connectivity estimates were thresholded at PSI ≥ .65, and for ease of visualization only the top 10% of those connections are shown. Each frequency bandwidth of interest is shown for participants who eventually responded well to ETX treatment (responders) or did not respond to ETX and continued to have seizures (nonresponders)
| DISCUSSION
The findings of this study, showing pretreatment effective connectivity differences during absence seizures in children with newly diagnosed and untreated CAE, provide new insights into the mechanisms of AED response variability in humans and the pathophysiology of human absence seizures. Our fMRI-informed MEG connectivity approach was used to investigate epileptic network pathways during these pretreatment absence seizures over multiple frequencies and with optimal spatial and temporal resolution. Specifically, we have shown that regions commonly identified by EEG-fMRI as critical for generating absence seizures (frontal cortex, precuneus, thalamus) have distinct connectivity patterns within low-and high-frequency bandwidths. In addition, participants who eventually became ETX treatment nonresponders were found to have decreased pretreatment parietal connectivity at low frequencies and increased frontal connectivity at high frequencies, with respect to those children who eventually became ETX treatment responders.
In general, there were stronger pretreatment connections in the posterior brain regions at low frequencies, whereas at higher frequencies stronger connections within frontal brain regions tend to predominate. Connectivity within the posterior brain regions is consistent with the robust "negative" BOLD signal change seen in our participants' EEGfMRI data as well as multiple previously published studies. 4, 7, 8, [11] [12] [13] The mechanism that drives this relationship between negative BOLD responses and low frequency connectivity during absence seizures is unclear but it supports the notion that a negative BOLD response may be a unique neurovascular mechanism. The importance of this posterior cortical "network" to the development of absence seizures has been supported by previous animal and human studies and may be related to the previously described posterior default mode network, thought to be associated with states of awareness. 11, [30] [31] [32] [33] Slow oscillations in posterior cortical regions (posterior cingulate, precuneus, parietal) may lead to development of GSWs that are then perpetuated by the frontal cortical and thalamic circuits. Alternatively, asynchronous oscillations within these anterior and posterior corticothalamic networks may occur normally, but an occurrence of synchronous oscillations may herald the transition to an ictal state. The mechanisms by which slow and fast oscillations interact to produce absence seizures is unclear; however, it is possible that a cross-frequency coupling, whereby the phase of the slow oscillations regulates the amplitude of faster frequencies, may be responsible. 34 This will be an important area of further study. We report differences in pretreatment connectivity during absence seizures when comparing participants based on their treatment response to ETX. This antiepileptic medication has been shown in a large clinical trial to be the best initial treatment for CAE; however, there is clearly variability in outcome with most patients responding well and becoming seizure free but approximately 20% with continued absence seizures.
1,2 Specifically, we have shown that ETX responders have increased pretreatment connectivity at low frequencies in the parietal (precuneus) region and ETX nonresponders have increased pretreatment connectivity at higher frequencies in the frontal cortex. ETX is presumed to have its major therapeutic effect by reducing low threshold T-type calcium channel currents in the thalamus. 35 A pharmacogenetic study of ETX efficacy in CAE identified 2 polymorphisms of the T-type calcium channel (CACNA1H rs61734410/P640L, CACNA1I rs3747178) that were more common in patients who were not seizure-
Average degree (number of edges) for each of the 41 nodes included in the connectivity analysis. Left, top, and right brain views are shown for each frequency bandwidth and each treatment outcome group. The color scale corresponds to the average degree. Nodes with significantly different number of connections are shown in the right column (P < .01 Delta and Gamma, P < .05 Beta, corrected for multiple comparisons). The nodes with significantly greater degree are circled with a black outline free, and in vitro studies showed that ETX's rate of calcium current decay was reduced for the P640L polymorphism seen in treatment nonresponders, compared to the wild-type channel. 3 The link between these genetic findings and the pretreatment ictal network that we have identified in this study is unclear; however, we speculate that if a child has a network driven by the frontal cortex, where ETX may not work as effectively as in the thalamus, then this may provide a mechanistic explanation for their poor response to the treatment ( Figure 5 ). The connection between genetic polymorphisms and the ictal network in medication nonresponders will be an important area of further investigation. In addition, even though this study used response to ETX to classify participants, the majority (4/5) of participants also did not respond to several subsequent treatments. It possible that the differences in connectivity are not specific to ETX responsiveness but instead describe a subgroup of CAEs that is overall medically refractory. This could be investigated more thoroughly in a larger study with more participants. The increased parietal connectivity observed in ETX treatment responders is somewhat unclear; however, this medication has been shown to decrease persistent sodium and calcium-activated potassium currents not only in the thalamus but also in layer V pyramidal neurons in the cortex. 36, 37 In addition, in animal models of absence epilepsy, abnormally elevated cortical glutamate levels have been found that are subsequently normalized with ETX treatment. 38 These provide possible mechanisms for how decreased parietal cortical connectivity could contribute to lack of treatment response. There are several limitations of the current study to consider. Our analysis was limited by the small size of the current cohort, especially for the ETX treatment nonresponder group. Given that approximately 20% of patients with CAE will become ETX treatment nonresponders, a larger sample of newly diagnosed patients with CAE would be important for validation of our findings. Second, the duration of epilepsy prior to diagnosis may vary between participants due to subtle clinical changes and the level of caregiver recognition. This introduces a possible confounder, which is difficult to address in the current study. Third, the reliability and repeatability of our connectivity measure remain unclear and we were unable to assess this in our study, since our participants had only a single MEG recording session. However, it will be important to study the reproducibility of these measures as they relate to seizures. The reduced sensitivity of MEG for subcortical structures in combination with our small sample size may have led to a lack of differences in thalamic connectivity between our ETX treatment groups. We saw some trend for increased thalamic connectivity in the ETX treatment responders, but this did not meet statistical thresholds, so differences in thalamic connectivity remain unclear. In addition, although we have shown that there is co-occurring connectivity in low and high frequency bandwidths in this and previous studies, how these different frequencies interact to produce absence seizures remains unclear. A promising technique to explore these frequency interactions further would be cross-frequency coupling, and specifically phase-amplitude coupling. [38] [39] [40] [41] Finally, it is unclear whether fMRI prior information improves the MEG connectivity result over that which could be obtained by doing whole brain analysis without a priori spatial information.
This study identified pretreatment connectivity differences between participants with CAE who responded well to ETX treatment and those who were treatment nonresponders. This provides, for the first time, a possible mechanistic explanation for the variable treatment response seen in patients that, electroclinically, share the same epilepsy syndrome. Our fMRI-informed MEG effective connectivity analysis outlines a novel way to explore these epileptic F I G U R E 5 Schematic representing a possible mechanism for absence seizure generation and ETX treatment responsiveness. Three major brain areas have been identified as responsible for the generation of childhood absence seizures (thalamus, frontal cortex, parietal cortex). Our data have shown a posterior cortical thalamic network at low frequencies (blue) and a co-occurring frontal cortical thalamic network at higher frequencies (green). ETX is thought to exert its major antiepileptic effect as a thalamic T-type calcium channel antagonist. We have shown in the current study that CAE participants who become ETX treatment nonresponders have an increase in frontal cortex connections at the time of diagnosis and prior to treatment. This increased frontal cortical connectivity is a possible mechanistic explanation for their eventual treatment nonresponsiveness
